Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings.
COVID-19
SARS-CoV-2
children
household
seroprevalence
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
11
01
2021
received:
20
08
2020
accepted:
15
01
2021
pubmed:
21
1
2021
medline:
2
6
2021
entrez:
20
1
2021
Statut:
ppublish
Résumé
Weather and the susceptibility of children to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is still a debated question and currently a hot topic, particularly in view of important decisions regarding opening schools. Therefore, we performed this prospective analysis of anti-SARS-CoV-2 immunoglobulin G (IgG) antibodies in children with known household exposure to SARS-CoV-2 and compared their IgG status with the other adults exposed to the index case in the same household. A total of 30 families with a documented COVID-19 index case were included. A total of 44 out of 80 household contacts (55%) of index patients had anti SARS-CoV-2 IgG antibodies. In particular, 16/27 (59,3%) adult partners had IgG antibodies compared with 28/53 (52,3%) of pediatric contacts (p > .05). Among the pediatric population, children ≥5 years of age had a similar probability of having SARS-CoV-2 IgG antibodies (21/39, 53.8%) compared to those less than 5 years old (7/14, 50%) (p > .05). Adult partners and children also had a similar probability of having SARS-CoV-2 IgG antibodies. Interestingly, 10/28 (35.7%) of children and 5/27 (18.5%) of adults with SARS-CoV-2 IgG antibodies were previously diagnosed as COVID-19 cases. Our study shows evidence of a high rate of IgG antibodies in children exposed to SARS-CoV-2. This report has public health implications, highlighting the need to establish appropriate guidelines for school openings and other social activities related to childhood.
Identifiants
pubmed: 33470561
doi: 10.1002/ppul.25280
pmc: PMC8014267
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1374-1377Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
Pediatr Pulmonol. 2021 Jun;56(6):1374-1377
pubmed: 33470561
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025
pubmed: 32759921
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Front Pediatr. 2020 Apr 30;8:215
pubmed: 32426311
Aging Clin Exp Res. 2020 Aug;32(8):1613-1620
pubmed: 32529595